Compare Eli Lilly And Co (LLY) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Schwab US Dividend Equity ETF — how do they compare? Eli Lilly And Co trades at $1,214.24 (market cap $1.08T), while Schwab US Dividend Equity ETF trades at $34.27. The key difference: Eli Lilly And Co pays a 0.57% dividend while Schwab US Dividend Equity ETF pays none. Which is the better fit depends on your goals.
| LLY | SCHD | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.24K | $34.27 |
52-Week Low | $639.43 | $26.44 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
